Health
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial – The Lancet
BBV152 was highly efficacious against laboratory-confirmed symptomatic COVID-19 diseasein adults. Vaccination was well tolerated…
We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The…
Continue Reading
-
Noosa News24 hours agoAndrew Burow: Link to alleged attacker uncovered in suspected murder of Kelvin Grove father
-
Noosa News23 hours agoCommunity backs Islamic College of Brisbane after bomb threat
-
Noosa News13 hours agoMurray Watt slams Queensland LNP renewable energy policy
-
General17 hours agoRyan Routh to face court charged with attempted assassination of Donald Trump